The Carnegie Innovation Fund has committed to invest up to $5 million in NSW-based prostate cancer diagnostic company Minomic International. [ + ]

Bionomics (ASX:BNO) shares grew 12.4% in two days after Standard & Poor's added the company to the S&P All Ordinaries index during its latest rebalance. [ + ]

Portions of the gorilla genome are closer to humans than we are to chimpanzees, shedding light on the evolution of our species. [ + ]

A Murdoch University researcher has helped rewrite history after radiocarbon dating and genetic analysis proved that Scandinavian conifers in the high arctic survived the last ice age for several thousands of years. Until now, it was presumed that the Scandinavian landscape was devoid of trees during the ice age. [ + ]

University of Wollongong scientists are behind the establishment of a global consortium which is using sunlight to convert water into important chemical fuels such as hydrogen gas. The research promises a significant reduction of greenhouse gas emissions by reducing CO₂ from fossil fuel use. [ + ]

Roche now offers an updated portfolio for the early detection of hepatitis C virus (HCV) infection and personalised disease management. Its improved diagnostics and patient monitoring tools allow for HCV testing with high performance in early infection and ease of use, allowing clinicians to work efficiently and to suit individual patient treatment. [ + ]

Lonza has launched its new global company website which will provide users with the company's complete life science market representation. [ + ]

A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer. The study builds on previous research which found that women using oral contraception have a temporarily increased risk of breast cancer and cervical cancer and a decreased risk of ovarian cancer and cancer of the lining of the womb. [ + ]

United Bioresearch has been appointed Australian distributor for the full range of ACTGene products. [ + ]

AusBiotech has announced the final chance for biotech business development professionals to attend the annual dedicated Business Development Forum and Workshop (BD Forum) in Queensland. [ + ]

Japan's Nippon Zoki Pharmaceutical has agreed to assess Phosphagenics' (ASX:POH) TPM/diclofenac pain patch for its suitability in the Japan and US markets. [ + ]

Drug discovery can be enormously expensive when a drug becomes a disaster. Professor Susan Charman’s team is working to fix potential problems early in the drug-development process. [ + ]

Australian research into shark antibodies that holds out the potential for new drugs and diagnostic agents is a step closer to realising its goal following an agreement with international diagnostic and pharmaceutical giant Roche. The pioneering work, which has attracted worldwide interest, is based on research led by Associate Professor Michael Foley at the La Trobe Institute of Molecular Science (LIMS). [ + ]

DuPont subsidiary Pioneer Hi-Breed and agricultural research body ACPFG have expanded a longstanding agreement to collaborate on agricultural biotechnology R&D. [ + ]

An international consortium comprising around 100 scientists and mathematicians, including Australian researchers, has for the first time pooled shared knowledge and data to deliver a holistic understanding of the biological changes in a cell. The findings of the Bacillus Systems Biology (BaSysBio) project, published in leading journal Science, will ultimately lead to the development of new drugs to protect people against antibiotic-resistant infections, including golden staph. [ + ]